Charles Schwab Corporation (The)$108.28MS · NYSE
The supplied consensus is Hold across 24 analysts, with a mean target of $243; the low and high are unavailable, so the full spread cannot be quantified. Other aggregators show a wider and less constructive picture: Benzinga cites a $190 consensus from 23 analysts, while Investing.com and MarketScreener show an average target of $221.76 and MarketBeat lists $224.75. UBS is the most bullish named source, raising its Buy target to $260; CFRA’s $108 target is the lowest cited, although it dates to April 2024. The only explicit recent revision is UBS’s increase from $255 to $260. The substantive disagreement concerns earnings growth, valuation multiples, and the durability of new product expansion.
